Objective: To determine whether there is a correlation between antimüllerian hormone (AMH) and stem cell factor (SCF) in serum, follicular fluid (FF), and granulosa cells (GCs), and to investigate a possible regulatory mechanism of AMH on SCF in human granulosa cells.
Design: Prospective clinical and experimental study.
Setting: Academic center.
Patient(s): 163 women undergoing IVF.
Intervention(s): Serum, FF, and GCs obtained in all women, primary cultures of human GCs.
Main Outcome Measure(s): AMH and SCF were analyzed in serum, FF, and GCs, using enzyme-linked immunosorbent assay, reverse-transcription polymerase chain reaction, and immunoblotting.
Result(s): There was a significant negative correlation between AMH and SCF protein level in FF, and in the mRNA expression of AMH and SCF in GCs. Conversely, there was no correlation between AMH and SCF levels in serum. In primary cultures of human GCs, SCF was down-regulated by treatment with recombinant human AMH and was increased by cyclic adenosine 3':5' monophosphate (cAMP) in a dose-dependent manner. A protein kinase A (PKA) inhibitor (H89) significantly reversed the effects of recombinant human AMH and cAMP on SCF mRNA and protein expression.
Conclusion(s): This is the first report on a modulatory role for AMH as an ovarian/follicular autocrine/paracrine factor controlling SCF expression via the cAMP/PKA pathway.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2014.08.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods.
Pharmacol Rev
February 2024
Center for Environmental Health Sciences, Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi (B.L.F.K.); Charles River Laboratories, Inc., Horsham, Pennsylvania (A.M.H.); Retired, National Center for Toxicological Research, Jefferson, Arkansas (W.S.); University of Georgia, Athens, Georgia (M.A.S.); Department of Pharmacological and Biomolecular Sciences, 'Rodolfo Paoletti' Università degli Studi di Milano, Milan, Italy (E.C.); US Environmental Protection Agency, Research Triangle Park, North Carolina (T.B.K.); Dow, Inc., Midland, Michigan (M.S.M.); Howard University College of Medicine, Washington DC (S.K.S.); Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, Maryland (S.C.F.); Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts (M.H.R.); and National Center for Toxicological Research, US Food and Drug Administration, Silver Spring, Maryland (D.L.M.).
Animals and animal models have been invaluable for our current understanding of human and animal biology, including physiology, pharmacology, biochemistry, and disease pathology. However, there are increasing concerns with continued use of animals in basic biomedical, pharmacological, and regulatory research to provide safety assessments for drugs and chemicals. There are concerns that animals do not provide sufficient information on toxicity and/or efficacy to protect the target population, so scientists are utilizing the principles of replacement, reduction, and refinement (the 3Rs) and increasing the development and application of new approach methods (NAMs).
View Article and Find Full Text PDFProtective Effects of Boric Acid Taken in Different Ways on Experimental Ovarian İschemia and Reperfusion.
Biol Trace Elem Res
June 2024
Department of Histology and Embryology, Faculty of Medicine, Erciyes University, 38039, Kayseri, Turkey.
Article Synopsis
- Ovarian ischemia, often caused by ovarian torsion, is a critical condition impacting women of reproductive age, leading to decreased ovarian reserve; this study explores the effects of boric acid treatment on ovarian damage in female rats during ischemia/reperfusion.* -
- Researchers created seven groups of rats, applying different methods of boric acid administration to assess its impact on histopathological changes, oxidative stress, and DNA integrity after ovarian ischemia and subsequent reperfusion.* -
- Results showed that boric acid significantly mitigated inflammation and preserved ovarian follicle structure, improved biochemical markers like AMH, and reduced oxidative stress and DNA damage, indicating its potential therapeutic effects on ovarian ischemia injuries.*
Nonylphenol Exposure-Induced Oocyte Quality Deterioration Could be Reversed by Boric Acid Supplementation in Rats.
Biol Trace Elem Res
September 2023
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, 38039, Kayseri, Turkey.
Article Synopsis
- - This study investigates the protective effects of boric acid on female rat oocytes exposed to nonylphenol (NP), highlighting its potential in preserving ovarian quality and function.
- - Histopathological and biochemical analyses revealed that boric acid mitigated tissue damage, restored hormone levels, and provided DNA protection, suggesting its positive impact on ovarian health.
- - The findings indicate that boric acid may effectively counteract the negative effects of NP, reducing oxidative stress and inflammation, and thus plays a protective role against infertility caused by NP exposure.
Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis.
Clin Endocrinol (Oxf)
July 2023
Erasmus MC, Sophia Children's Hospital, DSD-Expert Center, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Objective: Individuals with 45,X/46,XY or 46,XY gonadal dysgenesis are at increased risk of germ cell malignancies. Therefore, prophylactic bilateral gonadectomy is advised in girls and considered in boys with atypical genitalia for undescended, macroscopically abnormal gonads. However, severely dysgenetic gonads may not contain germ cells rendering gonadectomy unnecessary.
View Article and Find Full Text PDFSperm-carried IGF2 downregulated the expression of mitogens produced by Sertoli cells: A paracrine mechanism for regulating spermatogenesis?
Front Endocrinol (Lausanne)
December 2022
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Introduction: Insulin-like growth factor 2 (IGF2) mRNA has been found in human and mouse spermatozoa. It is currently unknown whether the IGF2 protein is expressed in human spermatozoa and, if so, its possible role in the cross-talk between germ and Sertoli cells (SCs) during spermatogenesis.
Methods: To accomplish this, we analyzed sperm samples from four consecutive Caucasian men.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!